Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “PASTEURELLA”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 991 records · Page 55Linked to original sources

Meningitis and bacteremia caused by Pasteurella ureae. Report of a case following intracranial surgery.

An otherwise healthy 53-year-old woman underwent intracranial surgery for trigeminal neuralgia. One week later she developed meningitis and bacteremia caused by Pasteurella ureae and was treated successfully with antimicrobials. This organism is known to colonize the respiratory tract in certain individuals and is an extremely rare cause of meningitis or bacteremia. This is the first reported case of bacteremia in an adult.

Female↗

Immunologic response to turkey poults of various ages to an avirulent Pasteurella multocida vaccine in the drinking water.

Fowl cholera has been reported in turkey poults in South Carolina between 5 and 6 weeks of age. An experiment was conducted to determine the earliest age that poults could be vaccinated with the Clemson University Pasteurella multocida strain (using the drinking water route) that would result in an effective immunity at 5 to 6 weeks of age. In group of vaccinates challenged with a virulent P. multocida (P-1059 strain) at 5 weeks of age, none were infected in groups vaccinated at either 20 days or at 25 days, 1 of 10 vaccinated at 15 days, 3 of 10 vaccinated at 10 days, 6 of 10 vaccinated at 5 days, and 8 of 10 became infected of those vaccinated at 1 day of age. Eight of 10 of each of 2 group of nonvaccinates developed evidence of infection. In groups of vaccinated challenged at 12 weeks of age, 2 of 10 turkeys became infected that had been vaccinated at 25 days of age, 4 of 10 that had been vaccinated at 20 days, 8 of 10 vaccinated at 15 days, 8 of 10 vaccinated at 10 days, 8 of 9 vaccinated at 5 days, and 8 of 9 became infected of those vaccinated at 1 day of age. All 10 of one group of nonvaccinates and all 9 of a second group developed evidence of infection. These results suggest, under the conditions of this experiment, the turkey poults vaccinated at 35 days of age and poults vaccinated at 20 days of age experienced an excellent immunological respone by 5 weeks of age. This response was less evident but, for the most part, still present, at 12 weeks of age.

Administration, Oral↗

The ability of blood plasma from drinking water vaccinated turkeys to protect against a lethal challenge of Pasteurella multocida.

Turkeys were vaccinated against fowl cholera with the Clemson University avirulent Pasteurella multocida vaccine strain (C.U. strain), using the drinking water route. Plasma was harvested from these turkeys, which later withstood challenge with a highly virulent P-1059 strain of P. multocida. Baby chicks were injected between the thigh and abdominal cavity with the immune plasma and simultaneously, into the breast muscle, with the same highly virulent strain referred to in the foregoing. The results demonstrated that plasma from turkeys vaccinated by the drinking water route protected baby chicks against intramuscular challenge with a virulent strain of P. multocida and suggest that a favorable systemic immunologic response did occur. This is in contrast to the Minnesota M-2283 strain which, reportedly, produces a localized protection only, when used as a drinking water vaccine.

Administration, Oral↗

The response of turkeys to varying doses of live oral Pasteurella multocida vaccine.

Groups of 30 turkeys were vaccinated by the drinking water route against fowl cholera with varying doses of the low virulence, CU strain, of Pasteurella mulocida. One group (heavy dose) received 1.2 x 107, another (medium dose) 1.5 x 105, and a third (light dose) 1.0 x 103 bacteria per ml. of drinking water. Two (6.7%) vaccine induced cholera deaths occurred in the heavy dose group. No deaths resulted in the other groups. Maximum serum antibody titers per group were; light dose 1:32, medium dose 1:128, and heavy dose 1:256. Three weeks after vaccination all turkeys were challenged with a large dose of virulent P. multocida (P-1059). Mortalities resulting from the challenge were 100% in the light group, 23% in the medium group, 4% in the heavy group, and 100% in the unvaccinated controls.

Administration, Oral↗

Acquired resistance in turkey poults to Pasteurella multocida (P-1059 strain) during aflatoxin consumption.

The potential for impairment by aflatoxin of the development of acquired immunity to fowl cholera in 8 week old turkey poults from a commercial flock was investigated by challenge of vaccinated poults at 10, 12, and 16 weeks of age. Sixty poults were allotted to 4 groups: A) aflatoxin fed, nonvaccinated; B) aflatoxin fed, vaccinated; C) control fed, nonvaccinated; and D) control fed, vaccinated. Aflatoxin B-1 (.5 ppm) was added to the control ration of groups A and B from 49 to 70 days of age. The avirulent CU (Clemson University) strain of Pasteurella multocida drinking water vaccine was given for one day to groups B and C. Challenge (5 poults from each group) was by administration of the virulent (P-1059) strain of P. multocida in the drinking water for 4 consecutive days. The presence of aflatoxin B-1 (.5 ppm) in the feed during oral vaccination with the avirulent strain of P. multocida did not impair the development of acquired resistance to later challenge with the virulent strain. Results indicate that age of poults and method of vaccination may be important factors in the development of acquired resistance to fowl cholera when aflatoxin is present in the diet.

Administration, Oral↗

Subcutaneous vaccination of chickens with a live, avirulent Pasteurella multocida, Vaccine.

The immunogenic responses to various routes of vaccination of broiler-type chickens to the Clemson University strain of Pasteurella multocida were evaluated. Broilers were vaccinated at 9 or 10 weeks of age using the oral (drinking water), palatine cleft, ocular, or subcutaneous injection routes. All birds were challenged at 11 or 12 weeks of age with virulent X-73 strain of P. multocida by the palatine cleft method. The degree of efficacy of the various vaccination routes differed among three experiments. Nevertheless, the subcutaneous route produced the greatest degree of protection in all experiments and in two experiments differences were highly significant (P less than .01). Protection levels as high as 95% and 97.5% were attained in broilers vaccinated subcutaneously and no undesirable lesions or cheesy masses formed under the skin in the back of the necks of broilers.

Administration, Oral↗

Immunity to Pasteurella multocida in protein-deficient chickens.

Studies were conducted to determine the effects of dietary protein restriction on the humoral immunity (HI) and cell-mediated immunity (CMI) of chickens. New Hampshire chickens were separated into two dietary treatment groups: basal, containing 3,200 kcal/kg and 21% protein; or protein restricted (PR), containing 3,200 kcal/kg and 7% protein. In studies involving HI, half of the birds in each dietary treatment were vaccinated against fowl cholera at 4 and 8 wk of age. Blood samples were collected weekly beginning at 4 wk of age. Overall, unvaccinated birds had lower titers than vaccinated birds and PR groups generally showed lower titers than basal groups. All birds were challenged by palatine cleft inoculation of live, virulent Strain X-73 of Pasteurella multocida. The vaccinated PR group survived live challenge as well as the vaccinated basal group, but all unvaccinated birds died as a result of the challenge, regardless of antibody titer. In studies involving CMI, half of the birds in each dietary treatment were vaccinated at 5 wk of age. At 2 to 3 wk postvaccination, representative birds from each treatment were bled for total and differential blood counts. Also, birds were sacrificed and spleen cells collected. Cells were cultured in Roswell Park Memorial Institute (RPMI) medium with phytohemagglutinin-M (PHA-M), sonicated P. multocida (X-73), or RPMI only.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

The fate of Pasteurella multocida after intratracheal inoculation into turkeys.

Young adult turkeys were intratracheally inoculated with the P-1059 strain of Pasteurella multocida, and the fate of the organism was studied by quantifying the organism in various respiratory and systemic tissues at various times after the inoculation. The results showed that, in the first 2 h, on the order of 10(8) to 10(9) organisms deposited at the upper trachea multiplied in situ to gradually spread downwards to the lower respiratory tract. In the majority of turkeys, by 6 h postinoculation the organism invaded the circulatory system and multiplied vigorously in the liver and spleen. In some birds, however, the organism appeared to have reached the liver from the trachea instantaneously by an unidentified mechanism. Vaccination with inactivated vaccines protected turkeys from intratracheal challenge exposure, as well as from intramuscular inoculation.

Animals↗

The influence of major histocompatibility complex genotypes on resistance to Pasteurella multocida and Newcastle disease virus in turkeys.

Sublines homozygous for each of four MHC haplotypes were developed from randombred control populations of turkeys and challenged with Pasteurella multocida (capsular serogroup a, somatic serotype 3, 4) at 6 wk of age or Newcastle disease virus (NDV; Texas GB strain) at 4 wk of age. In addition, individuals from a randombred control line (RBC2) and a subline (F) of RBC2 long-term selected for increased 16-wk BW were included in most of the challenge trials. The duration of the challenge trials was 2 wk for both organisms. Mortality following challenge with P. multocida or NDV was higher in the F line than in its randombred control. The MHC genotypes differed in mortality following exposure to both organisms but the rankings of the genotypes were not the same for P. multocida and NDV. The increased susceptibility of the F line to both organisms could not be explained by known changes in the frequency of the MHC haplotypes.

Animals↗

Influence of growth selection in turkeys on resistance to Pasteurella multocida.

Four lines of turkeys, a randombred control (RBC2) started in 1966 and three sire lines (F, A, and B), were challenged with a field isolate of Pasteurella multocida (capsular serogroup A, somatic serotype 3, 4) at 6 wk of age. Line F, a subline of the RBC2 line, was selected for 28 generations for increased 16-wk BW and Lines A and B were primary breeding sire lines from two commercial breeders. Each bird was inoculated subcutaneously in the back of the neck with 1.2 x 10(7) washed bacteria. Mortality following challenge with P. multocida was higher in the sire lines (54 to 65%) than in the RBC2 line (26%). There was no significant difference in mortality among sire lines following challenge. These results suggest that the increased susceptibility to P. multocida in the F line in comparison to its control may be due to genetic changes resulting from selection for increased BW in this line.

Aging↗

[Paranasal sinusitis due to Pasteurella multocida].

A case of paranasal sinusitis due to Pasteurella multocida (P. multocida) is reported. A 39-year-old woman presented with chief complaints of rhinorrhea and headache. The patient kept a cat in her house and kept such close contact with it as to wake up by being licked every morning. Bacteriological examination revealed P. multocida isolated from her nasal discharge and also from the saliva of the cat kept by the patient. The two isolates were compatible with respect to biochemical properties, serotype and drug susceptibility. Therefore, P. multocida infection in this case was considered to have originated from the pet cat. P. multocida infection has been increasing recently. One of the reasons is a pet boom. In order to prevent acquiring the infection from a pet animal, we should have knowledge about this infection, advise the patient to avoid close contact with pets, and provide valuable information concerning these problems to society from the viewpoint of zoonosis.

Adult↗

Efficacy of doxycycline in a goat model of Pasteurella pneumonia.

The clinical efficacy of doxycycline (Doxycen, Cenavisa, Spain), a long-acting preparation, was evaluated for treatment of Pasteurella haemolytica infection in 6 goats. One goat was not infected and served as a control. The disease was induced by intratracheal inoculation of 10(7) to 10(9) cfu of P. haemolytica. Confirmation of respiratory disease was based on evidence of appropriate clinical signs. Before and after initiation of doxycycline treatment on day 10, each goat was examined daily. Three clinical responses to doxycycline treatment were noted. Mean rectal temperatures decreased from 40.1 degrees C to normal, while mean respiratory rate decreased from the pre-treatment value of 32 to 27/min after 4 days. Other clinical signs associated with pneumonia resolved within 3-5 days post treatment. In addition the minimum inhibitory concentration of DOTC for the P. haemolytica isolate was found to be < 0.5 microgram/ml. The present study indicates that DOTC may be a useful antimicrobial agent in the treatment of caprine pasteurellosis.

Animals↗

Septic arthritis caused by Pasteurella multocida.

A patient with rheumatoid arthritis developed an infection in the right hand after she administered an antibiotic capsule to her cat. Two weeks after this, septic arthritis developed in her right knee. The organism isolated was Pasteurella multocida, which is part of the feline normal oral flora. The infection was treated with penicillin and drainage.

Anti-Bacterial Agents↗

Prevalence of serologic types of Pasteurella multocida from 57 species of birds and mammals in the United States.

The serologic types of 265 isolates of Pasteurella multocida collected from 50 species of wild birds and seven species of wild mammals over a 22-yr period were determined with the gel diffusion precipitin test. Antigens prepared from these isolates reacted with reference P. multocida antisera representing serotypes 1, 2, 3, 4, 5, 6, 7, 8, 12, and 15. Antigens from some isolates reacted slightly with antisera from more than one serotype. Overall, gel precipitin reactions involving serotype 1 (65%) and 3 (20%) were the most prevalent.

Animals↗

Persistence of Pasteurella multocida in Nebraska wetlands under epizootic conditions.

Gleason Basin, a marsh located in the western part of the Rainwater Basin in Nebraska, was selected during the 1980 spring waterfowl migration as a study site to determine the presence and persistence of virulent Pasteurella multocida. Avian cholera mortality in migratory waterfowl using the Basin increased during a 2-wk period of a die-off beginning the first week of March when 2,409 carcasses were collected from the marsh. Study sites within the marsh were established for sampling water associated with and not associated with intact and scavenged carcasses. Isolations of virulent P. multocida were made from five of six study sites associated with either intact or scavenged carcasses for 3 days and from three of five non-carcass-associated study sites for 2 days. Recovery of these bacteria from this environment suggested a possible source of infection for susceptible waterfowl using the contaminated site.

Animals↗

Characteristics of Pasteurella multocida isolated from waterfowl and associated avian species in California.

Characteristics of Pasteurella multocida isolated from tissues of dead waterfowl and associated avian species found at 23 sites located in northern and central California, from January 1986 through January 1988 are reported. Two hundred ninety five isolates of P. multocida were obtained from 23 avian species. Most of the isolates belonged to the subspecies P. multocida multocida (63%), followed by P. multocida gallicida (37%), and by P. multocida septica (less than 1%). There appeared to be a higher prevalence of P. multocida multocida in Ross' geese (Chen rossi) and Snow geese (Chen coeruleus). All of the isolates belonged to somatic serotype 1, possessed the A capsule type and were susceptible to the 8 antimicrobial agents tested. None contained plasmid DNA.

Animals↗